Postmarketing Safety Studies: US FDA Defines ‘Good Cause’ For Missing Milestone Dates

 
• By Sue Sutter
  
Milestone one
Missed postmarketing safety study milestones may be excused for good cause. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Post-Marketing Regulation & Studies

More from Product Reviews